首页> 外文期刊>Journal of Clinical Pathology >Expression of c-kit in human osteosarcoma and its relevance as a prognostic marker
【24h】

Expression of c-kit in human osteosarcoma and its relevance as a prognostic marker

机译:c-kit在人骨肉瘤中的表达及其与预后的关系

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: To examine the prognostic relevance of c-kit expression in human osteosarcomas and to evaluate thernmutation status in exon 9 and exon 11 of the c-kit gene. Methods: c-kit expression was examined in 100 numan osteosarcomas by immunohistochemistry usingrnparaffin embedded tumour tissues, and capillary sequencing of genomic DNA was performed to search forrnmutations in exons 9 and 11 of the c-kit gene. Results: 20 osteosarcomas showed c-kit expression ranging from 5% to 90% (mean 5.9%; SD 16.74%).rnFurthermore, DNA sequences of exon 9 and exon 11 of the c-kit gene were not altered in these tumours. Overall and disease free survival analysis did not reveal any differences between patients with osteosarcomarnwith c-kit expression and those with c-kit negative tumours. Conclusions: C-kit expression is not a prognostic marker in patients with osteosarcoma. The proteinrnexpression is not linked to mutations in exon 9 or exon 11 of the c-kit gene. Therefore, these exons may notrnfunction as targets for treatment modalities based on the suppression of c-kit tyrosine kinase activity.
机译:目的:检查c-kit表达在人骨肉瘤中的预后相关性,并评估c-kit基因第9和第11外显子的突变状态。方法:采用石蜡包埋的肿瘤组织,通过免疫组织化学方法检测100例人骨肉瘤中c-kit的表达,并对基因组DNA进行毛细管测序,以寻找c-kit基因第9和11外显子的突变。结果:20例骨肉瘤的c-kit表达范围为5%至90%(平均5.9%; SD为16.74%)。此外,在这些肿瘤中,c-kit基因的外显子9和外显子11的DNA序列没有改变。总体和无病生存分析未显示具有c-kit表达的骨肉瘤患者与具有c-kit阴性肿瘤的患者之间的任何差异。结论:C-kit表达不是骨肉瘤患者的预后指标。蛋白表达与c-kit基因的外显子9或外显子11的突变无关。因此,基于抑制c-kit酪氨酸激酶活性,这些外显子可能无法作为治疗方式的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号